Article Menu
Need Help?
No Article Versions Notes Found
Cite
Renda, M.C.; Renda, D.; Piazza, A.; Calvaruso, G.; Fecarotta, E.; Giangreco, A.; Maggio, A. Role of Iron Metabolism Genetic Determinants in Response to Chelation Therapy in a Cohort of β-Thalassemia and Sickle Cell Syndromes Italian Patients. Thalass. Rep. 2014, 4, 2729. https://doi.org/10.4081/thal.2014.2729
Renda MC, Renda D, Piazza A, Calvaruso G, Fecarotta E, Giangreco A, Maggio A. Role of Iron Metabolism Genetic Determinants in Response to Chelation Therapy in a Cohort of β-Thalassemia and Sickle Cell Syndromes Italian Patients. Thalassemia Reports. 2014; 4(2):2729. https://doi.org/10.4081/thal.2014.2729
Chicago/Turabian StyleRenda, Maria Concetta, Disma Renda, Angela Piazza, Giuseppina Calvaruso, Emanuela Fecarotta, Antonino Giangreco, and Aurelio Maggio. 2014. "Role of Iron Metabolism Genetic Determinants in Response to Chelation Therapy in a Cohort of β-Thalassemia and Sickle Cell Syndromes Italian Patients" Thalassemia Reports 4, no. 2: 2729. https://doi.org/10.4081/thal.2014.2729
APA StyleRenda, M. C., Renda, D., Piazza, A., Calvaruso, G., Fecarotta, E., Giangreco, A., & Maggio, A. (2014). Role of Iron Metabolism Genetic Determinants in Response to Chelation Therapy in a Cohort of β-Thalassemia and Sickle Cell Syndromes Italian Patients. Thalassemia Reports, 4(2), 2729. https://doi.org/10.4081/thal.2014.2729
